Cell Free DNA in Mature B-cell Lymphoma

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRuijin Hospital

About this trial

The purpose of this study is to assess whether plasma cell free DNA is an accurate tool that can early and dynamically inform on treatment outcome and an accessible source of tumor DNA to track tumor clonal evolution.

Eligibility criteria

Qualifiers

Documented diagnosis of mature B-cell tumor according to WHO 2008 criteria

18 years or older

Disqualifiers

Chemotherapy before

Other tumors

Trial design

Treatments tested in this trial

  • peripheral blood collection

Treatment groups

320 Participants
are divided into 1 treatment group

Sponsors and collaborators